Mehmet Tar is a Vice President in the Healthcare team. He joined Apax in 2018 and is currently based in London. Mehmet has participated in key deals including Candela, Rodenstock, Acelity, Neuraxpharm and Vyaire.
Prior to joining Apax, Mehmet was a member of Temasek’s Investment Group in London.
Mehmet holds a first class honours degree in Economics and Management from the University of Oxford.
Mehmet serves on the boards of Vyaire and Rodenstock.
Mehmet is passionate about investing, and the independent thinking, teamwork and wide encompassing analysis that it entails. From first identifying a company and forming an investment thesis, to working with top executives to make that thesis come to life, Mehmet greatly enjoys the investment lifecycle.